Curative has conducted 14 million COVID-19 tests nationwide at more than 8,000 sites. In developing its test, Curative, according to its founders, anticipated supply chain issues, so a process was created that didn’t rely on the same supplies other companies use, preventing a supply shortage and allowing the company to maintain its weekly production quota of 1 million tests. He said Curative has “captured up to 10% of the daily COVID-19 test samples across the United States” in its brief nine-month history. The company’s CEO, Fred Turner, is a 26-year-old, Oxford-educated science and technology prodigy who in September 2020 told the scientific trade journal Cell Systems that he dropped out of college to pursue his interests, and that he started and pivoted two biotechnology companies in the Silicon Valley prior to starting Curative.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |